About NAD-dependent protein deacetylase sirtuin-7
NAD-dependent protein deacetylase sirtuin-7 (SIRT7) is a protein
from Homo sapiens identified by UniProt accession
Q9NRC8, 400 residues long.
MolForge cross-references it against 0 known binders and
255 disease associations.
Target properties
| Protein name | NAD-dependent protein deacetylase sirtuin-7 |
| UniProt accession | Q9NRC8 |
| Gene | SIRT7 |
| Organism | Homo sapiens |
| Length | 400 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (255)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.31
- hepatocellular carcinoma · score 0.12
- neoplasm · score 0.11
- cancer · score 0.10
- melanoma · score 0.10
- non-small cell lung carcinoma · score 0.09
- breast cancer · score 0.09
- insulin resistance · score 0.08
- oral squamous cell carcinoma · score 0.08
- Pallister-Hall syndrome · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NRC8-F1 | alphafold | PREDICTED | 87.99 | — |
Amino-acid sequence (400 residues)
MAAGGLSRSE RKAAERVRRL REEQQRERLR QVSRILRKAA AERSAEEGRL LAESADLVTE LQGRSRRREG LKRRQEEVCD DPEELRGKVR ELASAVRNAK YLVVYTGAGI STAASIPDYR GPNGVWTLLQ KGRSVSAADL SEAEPTLTHM SITRLHEQKL VQHVVSQNCD GLHLRSGLPR TAISELHGNM YIEVCTSCVP NREYVRVFDV TERTALHRHQ TGRTCHKCGT QLRDTIVHFG ERGTLGQPLN WEAATEAASR ADTILCLGSS LKVLKKYPRL WCMTKPPSRR PKLYIVNLQW TPKDDWAALK LHGKCDDVMR LLMAELGLEI PAYSRWQDPI FSLATPLRAG EEGSHSRKSL CRSREEAPPG DRGAPLSSAP ILGGWFGRGC TKRTKRKKVT
Explore NAD-dependent protein deacetylase sirtuin-7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets